{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:14:28Z","timestamp":1794374068306,"version":"4.9.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI172254"],"award-info":[{"award-number":["R01AI172254"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI121252"],"award-info":[{"award-number":["R01AI121252"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1P01AI125180"],"award-info":[{"award-number":["1P01AI125180"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI141993"],"award-info":[{"award-number":["U01AI141993"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1P01AI125180"],"award-info":[{"award-number":["1P01AI125180"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U54CA260563"],"award-info":[{"award-number":["U54CA260563"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1P01AI125180"],"award-info":[{"award-number":["1P01AI125180"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-002351"],"award-info":[{"award-number":["INV-002351"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL116271"],"award-info":[{"award-number":["T32HL116271"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL116271"],"award-info":[{"award-number":["T32HL116271"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41591-024-03278-y","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T06:02:08Z","timestamp":1727416928000},"page":"235-244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-6731","authenticated-orcid":false,"given":"Doan C.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian T.","family":"Hentenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Morrison-Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-3094","authenticated-orcid":false,"given":"Natalie S.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Castrillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Runnstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9262-2920","authenticated-orcid":false,"given":"Pedro A.","family":"Lamothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Lonial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4182-587X","authenticated-orcid":false,"given":"Ignacio","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6133-5942","authenticated-orcid":false,"given":"F. Eun-Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"3278_CR1","unstructured":"WHO. WHO COVID-19 dashboard. https:\/\/covid19.who.int (2024)."},{"key":"3278_CR2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.13115","volume":"309","author":"DC Nguyen","year":"2022","unstructured":"Nguyen, D. C. et al. COVID-19 and plasma cells: is there long-lived protection? Immunol. Rev. 309, 40\u201363 (2022).","journal-title":"Immunol. Rev."},{"key":"3278_CR3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.immuni.2022.05.004","volume":"55","author":"D Bhattacharya","year":"2022","unstructured":"Bhattacharya, D. Instructing durable humoral immunity for COVID-19 and other vaccinable diseases. Immunity 55, 945\u2013964 (2022).","journal-title":"Immunity"},{"key":"3278_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad353","author":"N Lasrado","year":"2023","unstructured":"Lasrado, N. & Barouch, D. H. SARS-CoV-2 hybrid immunity: the best of both worlds. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiad353 (2023).","journal-title":"J. Infect. Dis."},{"key":"3278_CR5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.13013","volume":"303","author":"DC Nguyen","year":"2021","unstructured":"Nguyen, D. C. et al. Plasma cell survival: the intrinsic drivers, migratory signals, and extrinsic regulators. Immunol. Rev. 303, 138\u2013153 (2021).","journal-title":"Immunol. Rev."},{"key":"3278_CR6","volume":"14","author":"DC Nguyen","year":"2024","unstructured":"Nguyen, D. C. et al. Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture. Sci. Rep. 14, 3616 (2024).","journal-title":"Sci. Rep."},{"key":"3278_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03647-4","author":"JS Turner","year":"2021","unstructured":"Turner, J. S. et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature https:\/\/doi.org\/10.1038\/s41586-021-03647-4 (2021).","journal-title":"Nature"},{"key":"3278_CR8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-022-04527-1","volume":"604","author":"W Kim","year":"2022","unstructured":"Kim, W. et al. Germinal centre-driven maturation of B cell response to mRNA vaccination. Nature 604, 141\u2013145 (2022).","journal-title":"Nature"},{"key":"3278_CR9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add5960","volume":"16","author":"M Prabhakaran","year":"2024","unstructured":"Prabhakaran, M. et al. Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates. Sci. Transl. Med. 16, eadd5960 (2024).","journal-title":"Sci. Transl. Med."},{"key":"3278_CR10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.immuni.2015.06.016","volume":"43","author":"JL Halliley","year":"2015","unstructured":"Halliley, J. L. et al. Long-lived plasma cells are contained within the CD19\u2212CD38hiCD138+ subset in human bone marrow. Immunity 43, 132\u2013145 (2015).","journal-title":"Immunity"},{"key":"3278_CR11","doi-asserted-by":"publisher","unstructured":"Joyner, C. J. et al. Generation of human long-lived plasma cells by developmentally regulated epigenetic imprinting. Life Sci. Alliance https:\/\/doi.org\/10.26508\/lsa.202101285 (2022).","DOI":"10.26508\/lsa.202101285"},{"key":"3278_CR12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112682","volume":"42","author":"M Duan","year":"2023","unstructured":"Duan, M. et al. Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses. Cell Rep. 42, 112682 (2023).","journal-title":"Cell Rep."},{"key":"3278_CR13","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s41590-022-01345-5","volume":"23","author":"X Liu","year":"2022","unstructured":"Liu, X., Yao, J., Zhao, Y., Wang, J. & Qi, H. Heterogeneous plasma cells and long-lived subsets in response to immunization, autoantigen and microbiota. Nat. Immunol. 23, 1564\u20131576 (2022).","journal-title":"Nat. Immunol."},{"key":"3278_CR14","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.immuni.2023.04.015","volume":"56","author":"MJ Robinson","year":"2023","unstructured":"Robinson, M. J. et al. Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespan. Immunity 56, 1596\u20131612 e1594 (2023).","journal-title":"Immunity"},{"key":"3278_CR15","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood-2014-02-555169","volume":"125","author":"HE Mei","year":"2015","unstructured":"Mei, H. E. et al. A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow. Blood 125, 1739\u20131748 (2015).","journal-title":"Blood"},{"key":"3278_CR16","volume":"9","author":"DC Nguyen","year":"2018","unstructured":"Nguyen, D. C. et al. Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion. Nat. Commun. 9, 3698 (2018).","journal-title":"Nat. Commun."},{"key":"3278_CR17","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.3389\/fimmu.2019.02138","volume":"10","author":"DC Nguyen","year":"2019","unstructured":"Nguyen, D. C., Joyner, C. J., Sanz, I. & Lee, F. E. Factors affecting early antibody secreting cell maturation into long-lived plasma cells. Front. Immunol. 10, 2138 (2019).","journal-title":"Front. Immunol."},{"key":"3278_CR18","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/s41590-022-01340-w","volume":"23","author":"J Tellier","year":"2022","unstructured":"Tellier, J. & Nutt, S. L. The secret to longevity, plasma cell style. Nat. Immunol. 23, 1507\u20131508 (2022).","journal-title":"Nat. Immunol."},{"key":"3278_CR19","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","volume":"357","author":"IJ Amanna","year":"2007","unstructured":"Amanna, I. J., Carlson, N. E. & Slifka, M. K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357, 1903\u20131915 (2007).","journal-title":"N. Engl. J. Med."},{"key":"3278_CR20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19, 383\u2013397 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"3278_CR21","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1086\/587643","volume":"197","author":"NB Halasa","year":"2008","unstructured":"Halasa, N. B., Gerber, M. A., Chen, Q., Wright, P. F. & Edwards, K. M. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J. Infect. Dis. 197, 1448\u20131454 (2008).","journal-title":"J. Infect. Dis."},{"key":"3278_CR22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/CVI.00396-10","volume":"18","author":"R Bodewes","year":"2011","unstructured":"Bodewes, R. et al. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin. Vaccin. Immunol. 18, 469\u2013476 (2011).","journal-title":"Clin. Vaccin. Immunol."},{"key":"3278_CR23","doi-asserted-by":"crossref","first-page":"e1002082","DOI":"10.1371\/journal.pbio.1002082","volume":"13","author":"AJ Kucharski","year":"2015","unstructured":"Kucharski, A. J. et al. Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data. PLoS Biol. 13, e1002082 (2015).","journal-title":"PLoS Biol."},{"key":"3278_CR24","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","volume":"361","author":"K Hancock","year":"2009","unstructured":"Hancock, K. et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361, 1945\u20131952 (2009).","journal-title":"N. Engl. J. Med."},{"key":"3278_CR25","first-page":"521","volume":"58","author":"J Katz","year":"2009","unstructured":"Katz, J. et al. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb. Mortal. Wkly Rep. 58, 521\u2013524 (2009).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"3278_CR26","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.4049\/jimmunol.1000091","volume":"185","author":"I Skountzou","year":"2010","unstructured":"Skountzou, I. et al. Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J. Immunol. 185, 1642\u20131649 (2010).","journal-title":"J. Immunol."},{"key":"3278_CR27","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1056\/NEJMc0907256","volume":"361","author":"DN Fisman","year":"2009","unstructured":"Fisman, D. N. et al. Older age and a reduced likelihood of 2009 H1N1 virus infection. N. Engl. J. Med. 361, 2000\u20132001 (2009).","journal-title":"N. Engl. J. Med."},{"key":"3278_CR28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ni.3684","volume":"18","author":"R Nachbagauer","year":"2017","unstructured":"Nachbagauer, R. et al. Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins. Nat. Immunol. 18, 464\u2013473 (2017).","journal-title":"Nat. Immunol."},{"key":"3278_CR29","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature07231","volume":"455","author":"X Yu","year":"2008","unstructured":"Yu, X. et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455, 532\u2013536 (2008).","journal-title":"Nature"},{"key":"3278_CR30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature06890","volume":"453","author":"J Wrammert","year":"2008","unstructured":"Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667\u2013671 (2008).","journal-title":"Nature"},{"key":"3278_CR31","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.4049\/jimmunol.1002932","volume":"186","author":"FE Lee","year":"2011","unstructured":"Lee, F. E. et al. Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect. J. Immunol. 186, 5514\u20135521 (2011).","journal-title":"J. Immunol."},{"key":"3278_CR32","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"3278_CR33","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood-2004-07-2507","volume":"105","author":"M Odendahl","year":"2005","unstructured":"Odendahl, M. et al. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 105, 1614\u20131621 (2005).","journal-title":"Blood"},{"key":"3278_CR34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4049\/immunohorizons.2100011","volume":"5","author":"NS Haddad","year":"2021","unstructured":"Haddad, N. S. et al. One-stop serum assay identifies COVID-19 disease severity and vaccination responses. Immunohorizons 5, 322\u2013335 (2021).","journal-title":"Immunohorizons"},{"key":"3278_CR35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ni.3348","volume":"17","author":"J Tellier","year":"2016","unstructured":"Tellier, J. et al. Blimp-1 controls plasma cell function through the regulation of immunoglobulin secretion and the unfolded protein response. Nat. Immunol. 17, 323\u2013330 (2016).","journal-title":"Nat. Immunol."},{"key":"3278_CR36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ni.2524","volume":"14","author":"N Pengo","year":"2013","unstructured":"Pengo, N. et al. Plasma cells require autophagy for sustainable immunoglobulin production. Nat. Immunol. 14, 298\u2013305 (2013).","journal-title":"Nat. Immunol."},{"key":"3278_CR37","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.celrep.2018.07.084","volume":"24","author":"WY Lam","year":"2018","unstructured":"Lam, W. Y. et al. Metabolic and transcriptional modules independently diversify plasma cell lifespan and function. Cell Rep. 24, 2479\u20132492 e2476 (2018).","journal-title":"Cell Rep."},{"key":"3278_CR38","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3389\/fimmu.2019.01787","volume":"10","author":"AE Palm","year":"2019","unstructured":"Palm, A. E. & Henry, C. Remembrance of things past: long-term B cell memory after infection and vaccination. Front. Immunol. 10, 1787 (2019).","journal-title":"Front. Immunol."},{"key":"3278_CR39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2023.03.001","volume":"56","author":"A Nellore","year":"2023","unstructured":"Nellore, A. et al. A transcriptionally distinct subset of influenza-specific effector memory B cells predicts long-lived antibody responses to vaccination in humans. Immunity 56, 847\u2013863 e848 (2023).","journal-title":"Immunity"},{"key":"3278_CR40","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/jamainternmed.2020.5664","volume":"180","author":"EM White","year":"2020","unstructured":"White, E. M. et al. Asymptomatic and presymptomatic severe acute respiratory syndrome coronavirus 2 infection rates in a multistate sample of skilled nursing facilities. JAMA Intern. Med. 180, 1709\u20131711 (2020).","journal-title":"JAMA Intern. Med."},{"key":"3278_CR41","doi-asserted-by":"publisher","unstructured":"Shang, W. et al. Percentage of asymptomatic infections among SARS-CoV-2 Omicron variant-positive individuals: a systematic review and meta-analysis. Vaccines https:\/\/doi.org\/10.3390\/vaccines10071049 (2022).","DOI":"10.3390\/vaccines10071049"},{"key":"3278_CR42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s41182-022-00490-9","volume":"50","author":"EM El-Ghitany","year":"2022","unstructured":"El-Ghitany, E. M. et al. Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study. Trop. Med Health 50, 98 (2022).","journal-title":"Trop. Med Health"},{"key":"3278_CR43","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1093\/cid\/ciac237","volume":"75","author":"N Garrett","year":"2022","unstructured":"Garrett, N. et al. High asymptomatic carriage with the omicron variant in South Africa. Clin. Infect. Dis. 75, e289\u2013e292 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"3278_CR44","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ajpath.2022.01.007","volume":"192","author":"PA Christensen","year":"2022","unstructured":"Christensen, P. A. et al. Signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with coronavirus disease 2019 caused by the omicron variant of severe acute respiratory syndrome coronavirus 2 in Houston, Texas. Am. J. Pathol. 192, 642\u2013652 (2022).","journal-title":"Am. J. Pathol."},{"key":"3278_CR45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M20-3012","volume":"173","author":"DP Oran","year":"2020","unstructured":"Oran, D. P. & Topol, E. J. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann. Intern. Med. 173, 362\u2013367 (2020).","journal-title":"Ann. Intern. Med."},{"key":"3278_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad603","author":"ZR Tehrani","year":"2024","unstructured":"Tehrani, Z. R. et al. Deficient generation of spike-specific long-lived plasma cells in the bone marrow after severe acute respiratory syndrome coronavirus 2 infection. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiad603 (2024).","journal-title":"J. Infect. Dis."},{"key":"3278_CR47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104735","volume":"95","author":"AR Schulz","year":"2023","unstructured":"Schulz, A. R. et al. SARS-CoV-2 specific plasma cells acquire long-lived phenotypes in human bone marrow. EBioMedicine 95, 104735 (2023).","journal-title":"EBioMedicine"},{"key":"3278_CR48","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101726","volume":"75","author":"SS Mujtahedi","year":"2022","unstructured":"Mujtahedi, S. S. et al. Bone marrow derived long-lived plasma cell phenotypes are heterogeneous and can change in culture. Transpl. Immunol. 75, 101726 (2022).","journal-title":"Transpl. Immunol."},{"key":"3278_CR49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bcmd.2003.12.001","volume":"32","author":"C Pellat-Deceunynck","year":"2004","unstructured":"Pellat-Deceunynck, C. & Bataille, R. Normal and malignant human plasma cells: proliferation, differentiation, and expansions in relation to CD45 expression. Blood Cells Mol. Dis. 32, 293\u2013301 (2004).","journal-title":"Blood Cells Mol. Dis."},{"key":"3278_CR50","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-00264-6","volume":"6","author":"MF Bachmann","year":"2021","unstructured":"Bachmann, M. F., Mohsen, M. O., Zha, L., Vogel, M. & Speiser, D. E. SARS-CoV-2 structural features may explain limited neutralizing-antibody responses. NPJ Vaccines 6, 2 (2021).","journal-title":"NPJ Vaccines"},{"key":"3278_CR51","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3389\/fimmu.2019.00956","volume":"10","author":"MK Slifka","year":"2019","unstructured":"Slifka, M. K. & Amanna, I. J. Role of multivalency and antigenic threshold in generating protective antibody responses. Front. Immunol. 10, 956 (2019).","journal-title":"Front. Immunol."},{"key":"3278_CR52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41592-022-01450-1","volume":"19","author":"MC Woodruff","year":"2022","unstructured":"Woodruff, M. C. et al. Response under pressure: deploying emerging technologies to understand B-cell-mediated immunity in COVID-19. Nat. Methods 19, 387\u2013391 (2022).","journal-title":"Nat. Methods"},{"key":"3278_CR53","doi-asserted-by":"crossref","first-page":"e0293203","DOI":"10.1371\/journal.pone.0293203","volume":"18","author":"NS Haddad","year":"2023","unstructured":"Haddad, N. S. et al. Circulating antibody-secreting cells are a biomarker for early diagnosis in patients with Lyme disease. PLoS ONE 18, e0293203 (2023).","journal-title":"PLoS ONE"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03278-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03278-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03278-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T18:04:09Z","timestamp":1737482649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-024-03278-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3278"],"URL":"https:\/\/doi.org\/10.1038\/s41591-024-03278-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3979237\/v1","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.E.-H.L. is the founder of Micro-Bplex, Inc., serves on the scientific board of Be Biopharma, is a recipient of grants from the BMGF and Genentech, Inc., and has served as a consultant for Astra Zeneca. I.S. has consulted for GSK, Pfizer, Kayverna, Johnson & Johnson, Celgene, Bristol Myer Squibb and Visterra. F.E.-H.L., D.C.N. and I.S. are inventors of the patents concerning the plasma cell survival media related to this work (US11124766B2, US11125757B2 and Notice of Allowance issued 8\/5\/2024 for USPTO Patent Application 17\/405,918). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}